Cardioprotective agent due to its anti-inflammatory and anti-fibrotic activities in cardiomyocytes; inhibitor of purified canine angiotensin-converting enzyme (ACE) (IC50 = 0.65 μM); acts as a local co-modulator of bradykinin-induced vasodilation by inhibiting ACE and promoting nitric oxide release; blocks angiotensin II-induced smooth muscle cell proliferation and hypertrophy; exhibits anti-angiogenic and growth-inhibitory effects on endothelial cells.